CATrends: Unscented Deodorants and Antiperspirants
Lawsuits allege marketing doesn’t pass the smell test.
StemGenex
A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in November 2016. The complaint alleges that the company misleadingly markets its Stem Cell Treatments will treat diseases – including Alzheimer’s, Parkinson’s, and multiple sclerosis – and 100% of its prior customers are satisfied with its service without a reasonable basis for making such claims. In addition, the complaint alleges that the company omits important information about its Stem Cell Treatments, including the dissatisfaction and complaints of ineffectiveness from customers. (Moorer et al v. StemGenex Medical Group, Inc. et al, Case No. 16-cv-2816, S. D. CA.)
The Latest
HydroJug’s Heat-Retention Claims
Can these bottles really keep drinks hot for up to six hours?
With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
MLMs Are Consistently Leaving Participants Behind
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Bytech America’s Made in USA Claims
Marketing and reality are not in sync.